Early Cancer Detection Competitor Landscape Monitoring

Project Overview

A top diagnostics player wanted to monitor the commercial, clinical, research, and corporate activities in the public domain for three of the key players in the cancer early detection market.

DeciBio Approach

Secondary Research

Identified, reviewed, and aggregated press releases, clinical trial listings, conference presentations, research publications and regulatory / payor developments; extracted key information
Assessed trends in hiring / personnel from LinkedIn, including segmentation by function / department, and analysis of key new hires / departures

At a glance

Years spanned

Reports delivered

Market players monitored

Outcomes

Over the course of two years, DeciBio delivered quarterly reports summarizing public competitor activity and synthesis of the implications for the client. Report content included:

In-depth competitor profiles tracking key events and press releases
Summaries of competitor research and clinical activity
Summary of other relevant landscape development activities, including activity from emerging companies
Implications of these developments for the client and their competitive positioning

Timeline

2 years

Geographic Scope

Global

Industry

Clinical Diagnostics

capabilities

Competitive Analysis

Cell and Gene Therapy Services Landscape Assessment

Cell and Gene Therapy Service Market Opportunity Assessment

Synthetic Oligonucleotides Market Sizing

Early Cancer Detection Competitor Landscape Monitoring

Genetic Testing Lab Target Assessment

MRD Monitoring Market Assessment and Strategy

IVDR Diagnostics Strategy

Oncology Diagnostics Landscape Assessment and Model

Discover how we can help